4.2 Capitalization. Immediately prior to the Closing, the authorized share capital of the Company consists of the following:
(a) Ordinary Shares. A total of 4,363,824,941 authorized Ordinary Shares, of which 773,926,180 Ordinary Shares are outstanding and issued.
(b) Preferred Shares. A total of 200,000,000 authorized series seed preferred shares, par value US$0.00001 each (the “Series Seed Preferred Shares”), all of which are issued and outstanding; a total of 66,667,000 authorized series a-1 preferred shares, par value US$0.00001 each (the “Series A-1 Preferred Shares”), all of which are issued and outstanding; a total of 183,715,000 authorized series a-2 preferred shares, par value US$0.00001 each (the “Series A-2 Preferred Shares”), all of which are issued and outstanding; a total of 14,503,820 authorized series b-1 preferred shares, par value US$0.00001 each (the “Series B-1 Preferred Shares”) , none of which are issued and outstanding; and a total of 171,289,239 authorized series b-2 preferred shares, par value US$0.00001 each (the “Series B-2 Preferred Shares”, together with the Series Seed Preferred Shares, the Series A-1 Preferred Shares, the Series A-2 Preferred Shares and the Series B-1 Preferred Shares, the “Preferred Shares”), none of which are issued and outstanding.
(c) Options, Warrants, Reserved Shares. Except for (i) the conversion privileges of the Preferred Shares, (ii) the preemptive rights provided in the shareholders agreement to be entered into at the Closing in form and substance as set forth in Exhibit B (the “Shareholders Agreement”), (iii) the repurchase rights provided in the restricted share agreement to be entered into at the Closing in form and substance as set forth in Exhibit C (the “Restricted Share Agreement”), and (iv) up to 211,570,000 Ordinary Shares reserved under the ESOP (as defined below) immediately prior to the Closing, there are no options, warrants, conversion privileges or other rights, or agreements with respect to the issuance thereof, presently outstanding to purchase any equity interest or registered capital of any Group Company. Apart from the exceptions noted in the Transaction Documents (as defined below), no shares of any Group Company’s outstanding share capital, registered capital, or shares issuable upon exercise or exchange of any outstanding options or other shares issuable by any Group Company, are subject to any encumbrance, preemptive rights, rights of first refusal or other rights to purchase such shares (whether in favor of such Group Company or any other person).
(d) Outstanding Security Holders. Schedule II attached hereto sets forth the capitalization tables of the Company immediately prior to the Closing, and immediately after the Closing, in each case reflecting all then issued and outstanding shares of the Company (on a fully diluted basis).
4.3 Subsidiaries. None of the Company, the HK Company and the Domestic Companies presently owns or controls, directly or indirectly, any interest in any other corporation, partnership, trust, joint venture, association, or entity than a Group Company. No Group Company is obligated to make any investment in or capital contribution in or on behalf of any other person.
4